What companies are DNLI's competitors?

Denali Therapeutics Inc. (DNLI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does DNLI compare to its peers?

The peer comparison table on this page shows Denali Therapeutics Inc. (DNLI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does DNLI operate in?

Denali Therapeutics Inc. (DNLI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

DNLI

Denali Therapeutics Inc.

NASDAQ·Biotechnology · Healthcare

$23.83$0.93+4.06%

After hours·$23.93+0.42%

Market cap$3.78B·Market closed·Jul 21 8:00 PM UTC

Frequently Asked Questions About DNLI

What companies are DNLI's competitors?: Denali Therapeutics Inc. (DNLI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does DNLI compare to its peers?: The peer comparison table on this page shows Denali Therapeutics Inc. (DNLI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does DNLI operate in?: Denali Therapeutics Inc. (DNLI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

DNLI

Denali Therapeutics Inc.

NASDAQ·Biotechnology · Healthcare

$23.83$0.93+4.06%

After hours·$23.93+0.42%

Market cap$3.78B·Market closed·Jul 21 8:00 PM UTC

Peers


IBRX	ImmunityBio, Inc.	$8.07	$8.5B
LQDA	Liquidia Corporation	$80.89	$7.2B
COGT	Cogent Biosciences, Inc.	$39.64	$6.8B
RCUS	Arcus Biosciences, Inc.	$29.48	$3.0B
BEAM	Beam Therapeutics Inc.	$27.29	$2.8B
AGIO	Agios Pharmaceuticals, Inc.	$37.36	$2.2B
ETNB	89bio, Inc.	$14.84	$2.2B
GLPG	Galapagos N.V.	$27.98	$1.8B
VRDN	Viridian Therapeutics, Inc.	$19.18	$1.7B
RXRX	Recursion Pharmaceuticals, Inc.	$3.08	$1.4B

Frequently Asked Questions About DNLI

What companies are DNLI's competitors?: Denali Therapeutics Inc. (DNLI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does DNLI compare to its peers?: The peer comparison table on this page shows Denali Therapeutics Inc. (DNLI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does DNLI operate in?: Denali Therapeutics Inc. (DNLI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.